Atlas Trials

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Clinical trial NCT05833815 · RECRUITING

Trial details

NCT number
NCT05833815
Sponsor
Banaras Hindu University
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gallbladder Cancer
Start date
2022-11-01
Primary completion
2024-12-30
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.